Can Cancer Become a Manageable Disease?
Mason researchers Lance Liotta's and Emanuel Petricoin's discoveries in protein biomarker-based research will soon enable physicians to develop individualized treatment plans that match the right patient with the right drug.
These research breakthroughs hold promise for new personalized treatments for cancer patients, transforming cancer from a terminal disease into one that is in remission indefinitely.
Teamwork at Mason—A Habit of Excellence

















